Later studies showed that anti-CTLA-4 treatment induces a robust increase in both CD4+ and CD8+ T cell populations in several human cancers including lung cancer, thereby limiting T reg infiltration into the tumor bed and increasing T effector to T reg ratio (51, 55, 59, 66, 117) (Figure 1). Here, CD4 is linked to lung cancer.